The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease

BACKGROUND: Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glycaemic control would reduce the risk of future CVD or mortality in patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Autores principales: Bots, Sophie H., van der Graaf, Yolanda, Nathoe, Hendrik M. W., de Borst, Gert Jan, Kappelle, Jaap L., Visseren, Frank L. J., Westerink, Jan
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950600/
https://ncbi.nlm.nih.gov/pubmed/27431507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0418-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares